Diabetic foot is one of the most common chronic complications of diabetes mellitus. It involves a combination of peripheral neuropathy (nerve damage) and vasculopathy (microcirculation impairment), which reduce sensitivity, slow down healing, and increase the risk of infections. Without careful treatment, it can progress severely.
Ozempic is the brand name of the injectable drug based on semaglutide, originally developed for the treatment of type 2 diabetes, which has also shown significant effects on weight loss. However, to achieve sustainable results, it is necessary to integrate it with lifestyle changes and personalized medical monitoring.
The term "low-grade inflammation" may sound somewhat reassuring, but it's actually a key concept that can impact the health of our hearts in surprising ways. This article delves into the connection between low-grade inflammation and cardiovascular diseases, seeking to understand how these processes affect the well-being of our cardiovascular system.
Fasting blood glucose and glycated hemoglobin are commonly used parameters to diagnose diabetes. However, normal values of these traditional indicators do not allow us to detect sugar-related damage early, which always precedes the subsequent development of diabetes in a detectable manner.
Recognizing the symptoms of insulin resistance and adopting strategies to address it is crucial for promoting weight loss and maintaining a healthy body weight.
Assessing whether one has a genetic predisposition to type 2 diabetes allows for the implementation of dietary and supplement strategies with a preventive focus.
Two specific markers—glycated albumin and methylglyoxal—make it possible to accurately assess an individual’s inflammation status related to sugar metabolism.
Preventing diabetes by identifying genetic predispositions and lifestyle factors can significantly add healthy years of life. A personalized medicine approach is crucial to enhance quality of life and well-being, allowing occasional indulgences without compromising health.